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Abstract The endoplasmic reticulum is primarily recognized
as the site of synthesis and folding of secreted, membrane-
bound, and some organelle-targeted proteins. An imbalance
between the load of unfolded proteins and the processing ca-
pacity in endoplasmic reticulum leads to the accumulation of
unfolded or misfolded proteins and endoplasmic reticulum
stress, which is a hallmark of a number of storage diseases,
including neurodegenerative diseases, a number of metabolic
diseases, and cancer. Moreover, its contribution as a novel
mechanistic paradigm in genetic skeletal diseases associated
with abnormalities of the growth plates and dwarfism is con-
sidered. In this review, I discuss the mechanistic significance
of endoplasmic reticulum stress, abnormal folding, and intra-
cellular retention of mutant collagen types II and X in certain
variants of skeletal chondrodysplasia.
Keywords Endoplasmic reticulum stress . Unfolded protein
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Introduction
The endoplasmic reticulum (ER) is an eukaryotic organelle
responsible for synthesis, folding, trafficking, and sorting of
proteins. It also plays an important role in lipid and steroid
synthesis as well as calcium homeostasis (Engin and
Hotamisligil 2010; Hosoi and Ozawa 2009). An imbalance
between the load of unfolded proteins and the processing ca-
pacity in ER leads to the accumulation of unfolded or
misfolded proteins and ER stress (Ron and Walter 2007;
Schröder and Kaufman 2005; Sano and Reed 2013). To alle-
viate accumulation of unfolded proteins, the process being
toxic to cells, ER triggers an evolutionarily conserved signal-
ing cascade, named unfolded protein response (UPR) (Engin
and Hotamisligil 2010; Schröder and Kaufman 2005; Tsuru
et al. 2016; Lin et al. 2008). Adaptation and restoration of ER
function through UPR signaling comprise translational atten-
uation of global protein synthesis, upregulation of ER chaper-
ones and prevention from trafficking (to the proper subcellular
localizations), as well as degradation of unstable or partially
folded mutant proteins by an endoplasmic reticulum-
associated degradation (ERAD) system (Engin and
Hotamisligil 2010; Hosoi and Ozawa 2009; Ron and Walter
2007; Schröder and Kaufman 2005; Bernales et al. 2006). If
ER stress is excessive or prolonged and cannot be resolved,
signaling switches from prosurvival to proapoptotic (Hosoi
and Ozawa 2009; Szegezdi et al. 2006). ER stress and UPR
are critical for the normal cellular homeostasis and develop-
ment of the organism and are also known to play major roles
in the pathogenesis of many diseases such as neurodegenera-
tive (Uehara et al. 2006; Hoozemans et al. 2007; Perri et al.
2016) and cardiovascular (Minamino et al. 2010; Kassan et al.
2012) diseases, diabetes (Basha et al. 2012), obesity (Hosoi
et al. 2008), inflammation (Ha et al. 2015), and cancer (Suh
et al. 2012; Chhabra et al. 2015; Lin et al. 2008; Mahdi et al.
2016; Yoshida 2007a). In recent years, accumulating evidence
indicates that abnormal folding and accumulation of structural
proteins that are produced to fulfil their physiological function
in the extracellular space of tissues may lead to ER stress and
induction of a wide range of systemic diseases. For instance,
several reports linked ER stress to mutations in collagen type
II that induce various forms of spondyloepiphyseal dysplasia
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(SED) (Chung et al. 2009; Okada et al. 2015; Liang et al.
2014). Other studies highlight the role of ER stress in the
pathogenesis of metaphyseal (chondro) dysplasia, Schmid
type (MCDS), a disorder caused by mutations in the collagen
type X, characterized by expansion of the hypertrophic zone
of the growth plate resulting in dwarfism (Rajpar et al. 2009;
Ho et al. 2007; Mäkitie et al. 2010). Another studies point out
the crucial role of ER stress in diseases caused bymutations in
collagen type VI genes that lead to the mild to severe pheno-
type of myopathies, including Ullrich congenital muscular
dystrophy (UCMD) and Bethlem myopathy (BM) (De
Palma et al. 2014), or mutations in collagen type IV genes
(COL4A3/COL4A4/COL4A5) that contribute to the patho-
genesis of thin-basement-membrane nephropathy (TBMN)
and Alport syndrome (AS) (Pieri et al. 2014) and cataract
development (Firtina et al. 2009). Succeeding examples com-
prise ocular dysgenesis, myopathy, brain malformations, cere-
brovascular disease, and cerebral hemorrhages, all caused by
mutations in collagen type IV (COL4A1/COL4A2) (Kuo
et al. 2014; Jeanne et al. 2012; Verbeek et al. 2012;
Volonghi et al. 2010; Gould et al. 2007). Moreover, accumu-
lating evidence shows an association between mutations in
genes encoding proteins involved in type I procollagen pro-
cessing or chaperoning and pathogenesis of recessive variants
of osteogenesis imperfecta (OI), while dysregulation of mo-
lecular chaperones is implicated in ER stress in severe forms
of osteoarthritis (OA) (Lisse et al. 2008; Kelley et al. 2011;
Marini et al. 2010; Bodian et al. 2009; Symoens et al. 2013;
Nugent et al. 2009; Takada et al. 2011).
In this review, basic mechanisms of ER stress and its sig-
nificance in certain variants of chondrodysplasia caused by
mutations in collagen types II and X are discussed.
Endoplasmic reticulum stress
The endoplasmic reticulum is a membranous organelle and is
one of the major compartments for the biosynthesis, matura-
tion, and folding of proteins. The specialized intra-ER envi-
ronment contains several factors that are required for the for-
mation of disulfide bonds and for optimal protein folding,
including ATP, Ca2+, and unique oxidizing conditions. The
accuracy of protein folding is also monitored by Ca2+-depen-
dent molecular chaperones, such as glucose-regulated protein
78 kDa (Grp78/BiP), glucose-regulated protein 94 kDa
(Grp94), calreticulin (CRT), and calnexin (CNX) which stabi-
lize the protein folding intermediates and prevent the aggre-
gation of proteins in the ER (Szegezdi et al. 2006; Anelli and
Sitia 2008; Kim et al. 2008; Hetz 2012; Mahdi et al. 2016).
The physiological state of the ER is challenged when the
influx of the nascent unfolded or misfolded polypeptides ex-
ceeds the processing capacity of the ER (Schröder and
Kaufman 2005; Sano and Reed 2013). Correct protein folding
may fail as a result of gene mutations, RNA modifications,
amino acid misincorporation during translation, or unequal
synthesis of individual subunits of multisubunit protein spe-
cies. Furthermore, posttranslational modifications can be
caused by changes in pH, temperature, ionic strength, and
oxidative and other stresses (Kim et al. 2008; Hetz 2012;
Schröder 2008). The unfolded/misfolded proteins expose hy-
drophobic domains that are normally hidden within the cor-
rectly folded polypeptide’s structure. The interaction between
such inappropriately folded proteins may lead to their accu-
mulation within the cells. In turn, aggregates may interfere
with cellular functions and are potentially cytotoxic. Three
hypotheses have been proposed to explain cytotoxic mecha-
nisms: (i) the channel hypothesis suggesting that ring-shaped
oligomers form pores in cellular membranes, (ii) misfolded
proteins lead to dysfunction of normal proteins with which
they interact, and (iii) misfolding proteins may deplete com-
ponents of the quality control system, which consists of chap-
erone and degradation systems, thereby reducing their func-
tionality (Barral et al. 2004). To restore cellular integrity and
homeostasis, cells activate evolutionarily conserved adaptive
response, called UPR, that consists of several quality control
systems (Schröder and Kaufman 2005; Lin et al. 2008;
Szegezdi et al. 2006; Schröder 2008) that act in concert for
(i) inhibiting general protein translation, (ii) activating the sig-
naling pathways that lead to expression of molecular chaper-
ones and increasing folding capacity, and (iii) promoting the
degradation of misfolded proteins and reducing aggregation
(Engin and Hotamisligil 2010; Anelli and Sitia 2008; Kim
et al. 2008; Hetz 2012). UPR is mediated through activation
of three ER transmembrane receptors: inositol-requiring en-
zyme 1 (IRE1), activating transcription factor 6 (ATF6), and
protein kinase RNA-like endoplasmic reticulum kinase
(PERK). Under physiological conditions, all three factors re-
lated to ER stress are maintained in inactive form through their
association with Grp78 (Anelli and Sitia 2008). Upon accu-
mulation of unfolded proteins in the lumen of the ER, Grp78
dissociates from IRE1, ATF6, and PERK, which leads to their
activation and assistance in folding processes (Szegezdi et al.
2006; Anelli and Sitia 2008; Shen et al. 2002; Rutkowski and
Kaufman 2004). PERK is a type 1 transmembrane protein
kinase residing in the ER which is activated in response to
perturbation of protein folding and constitutes a signal trans-
ducer of the earliest phase of stress response (Liu et al. 2016).
UPR first alleviates the ER stress by diminishing the overall
protein load via PERK-mediated phosphorylation of the α
subunit of eukaryotic translation initiation factor 2 (eIF2α)
(Mahdi et al. 2016; Liu et al. 2016; Joshi et al. 2013; Zhang
et al. 2013). In turn, the decrease in eIF2 activity promotes the
translation of activating transcription factor 4 (ATF4) resulting
in the activation of CCAAT/enhancer binding protein
(C/EBP) homologous protein (CHOP) production, which pro-
motes ER stress-induced apoptosis (Ron and Walter 2007;
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Walter and Ron 2011; Fawcett et al. 1999; Jiang et al. 2004).
ATF6 is a basic leucine zipper (bZIP) transcription factor that
upon dissociation of Grp78 translocates to the Golgi complex,
in which it undergoes proteolytic cleavage by the serine pro-
tease (S1P) and the metalloprotease (S2P) (sites 1 and 2, re-
spectively) (Shen et al. 2002; Zhang et al. 2013; Nadanaka
et al. 2006). The cleaved 50 kDa cytoplasmic bZIP-containing
fragment translocates to the nucleus, where it binds to the ER
stress response element (ERSE) and activates genes involved
in the adaptive stress response, i.e., Grp78, CHOP, and X-box
binding protein 1 (XBP1) (Anelli and Sitia 2008; Nadanaka
et al. 2006; Brown et al. 2000). It has been shown that cell- or
tissue-specific UPR may exist under ER stress; for example,
cAMP response element binding protein H (CREBH) has
been identified as a regulated intramembrane proteolysis
(RIP)-regulated liver-specific transcription factor that is
cleaved upon ER stress (Zhang et al. 2006) while old astro-
cyte specifically induced substance (OASIS), which is
similar to the ATF6 family, has been identified as a transducer
of ER stress in astrocytes (Kondo et al. 2005). IRE1 is a type
1 transmembrane serine/threonine receptor protein kinase
which is activated via homodimerization and trans-
autophosphorylation upon dissociation from Grp78 (Hosoi
and Ozawa 2009; Zhang et al. 2013). The activated domain
of IRE1 acts like a nuclease and catalyzes the removal of a
small intron from XBP1 messenger RNA (mRNA) (Zhang
et al. 2013; Yoshida 2007b). This splicing creates a transla-
tional frameshift in XBP1 to produce an active transcription
factor which directly binds to the ERSE and the UPR element
(UPRE), leading to the upregulation of genes such as ER
chaperones, e.g., Grp78 gene (HSPA5) (Hosoi and Ozawa
2009; Suh et al. 2012; Anelli and Sitia 2008; Shen et al.
2002) (Fig. 1).
Protein quality control primarily promotes cell survival and
the maintenance of cellular homeostasis by switching on sev-
eral pathways of the adaptive response. One of the central ER
Fig. 1 Endoplasmic reticulum signaling triggers unfolded protein
response. Under physiological conditions, glucose-regulated protein
78 kDa (Grp78/BiP), protein disulfide isomerase (PDI), heat shock
protein 47 (HSP47), and other molecular chaperones are present in the
lumen of endoplasmic reticulum (ER). Additionally, Grp78 binds the ER
luminal domains of the three ER stress receptors, i.e., protein kinase
RNA-like endoplasmic reticulum kinase (PERK), activating transcription
factor 6 (ATF6), and inositol-requiring enzyme 1 (IRE1). Accumulation
of unfolded proteins in the ER, e.g., as a result of mutation in the collagen
gene, induces sequential dissociation of Grp78 from PERK (1), ATF6 (2),
and IRE1 (3), respectively, and their activation. Dissociated Grp78 mol-
ecules and other chaperones are mobilized to form complexes with un-
folded proteins aggregated in the ER. Activated PERK (via dimerization
and autophosphorylation) phosphorylates eukaryotic initiation factor 2α
(eIF2α). This phosphorylation suppresses general protein synthesis, thus
decreasing the entry of newly synthesized proteins into the ER and en-
abling translation of ATF4. ATF4 translocates to the nucleus and induces
the transcription of genes required to restore ER homeostasis including
that for CCAAT/enhancer binding protein homologous protein (CHOP).
ATF6 is activated by limited proteolysis after its translocation from the
ER to the Golgi apparatus. It is cleaved by site 1 and site 2 proteases (S1P,
S2P) releasing the cytoplasmic 50kDa domain (ATF650) which is an
active transcription factor. ATF650 regulates the expression of genes in-
volved in the unfolded protein response (UPR), including chaperones,
CHOP, and X-box binding protein 1 (XBP1) . Additionally, the activation
of XBP1 is carried out by IRE1. Activated IRE1 produces an unconven-
tional splice in cytoplasmic XBP1 mRNA. Spliced XBP1 protein
(sXBP1) translocates to the nucleus and upregulates the transcription of
genes encoding chaperones to increase the protein folding capacity of the
ER and genes controlling the endoplasmic reticulum-associated degrada-
tion (ERAD) system, a mechanism by which misfolded protein is
retrotranslocated into the cytoplasm and degraded in the proteasome.
This complex action aims to restore ER homeostasis by blocking unfold-
ed protein aggregation, inducing degradation of aggregated proteins and
enhancing folding capacity
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stress defense strategies is to upregulate coordinately its
chaperoning capacity. Chaperones are specialized proteins
that play a key role in cellular homeostasis by assisting in
protein folding, assembly of the macromolecular complexes,
protein transport, and cellular signaling (Ullman et al. 2008).
In the ER, the main function of chaperones is to prevent inap-
propriate aggregation of nascent peptide chains during protein
synthesis. Chaperones bind to and stabilize exposed hydro-
phobic domains of target proteins and promote proper folding
of newly synthesized proteins. This process involves cycles of
controlled binding and release of target polypeptides
(Horwich 2004; Chaudhuri and Paul 2006).While some chap-
erones non-specifically interact with a wide variety of poly-
peptides, others are restricted to specific subsets or even indi-
vidual proteins. Chaperones are expressed and maintained at
steady levels in unstressed cell; however, their expression is
highly upregulated during stress conditions. Dysregulated
chaperonic activity results in unfolded, misfolded, or aggre-
gated proteins that will eventually be targeted to degradation
pathways or accumulate in cells, leading to impairment of
function and eventually contributing to various diseases.
Apart from their critical role in protein folding, chaperones
also function as signal-transducing molecules by affecting
the transition between active and inactive states of signaling
molecules, changing their subcellular localization or affecting
protein-protein interactions (Engin and Hotamisligil 2010).
Interestingly, chaperones are able to distinguish between the
native and non-native states of targeted proteins, but how they
discriminate between correctly and incorrectly folded proteins
and how they target the latter for degradation are yet to be
explored (Vembar and Brodsky 2008). Apart from molecular
chaperones, the ubiquitin proteasome pathway (UPP) is re-
ferred to as the second part of a protein quality control system
(PQCS) and plays a critical role in cell function and survival.
It has been shown that disturbance in or impairment of the
UPP, which may be induced by the accumulation of misfolded
proteins in the ER or loss of function of the enzymes involved
in the ubiquitin conjugation and deconjugation pathway, leads
to altered UPP function, which positively affects the accumu-
lation of protein aggregates in the cell. The formation of olig-
omers and aggregates occurs in the cell when a critical con-
centration of misfolded protein is reached. Aggregated pro-
teins inside the cell often lead to the formation of Ban amyloid-
like structure,^ which eventually causes different types of de-
generative disorders and, ultimately, cell death (Anelli and
Sitia 2008). Finally, when correct folding is impossible and
degradation by the UPP is insufficient, then the UPR switches
from being prosurvival to proapoptotic (Engin and
Hotamisligil 2010; Schröder and Kaufman 2005). Typically,
excessive ER stress leads to apoptosis via an increase in the
expression of CHOP or by inducing caspase-dependent apo-
ptosis (Lin et al. 2008; Szegezdi et al. 2006; Chiribau et al.
Fig. 2 Quality control interplay in the BER-Golgi-lysosomes/
extracellular space axis.^ Extracellular space proteins, e.g., collagens,
are synthesized by ribosomes and translocated into the endoplasmic
reticulum (ER). In the ER, proteins accomplish their native form
(folding, assembling) under strict quality control mechanisms.
Appropriate folding/structure of the proteins enables their transport and
modification in the Golgi, followed by transport to the extracellular space
and/or to lysosomes. Accelerated aggregation of unfolded/misfolded pro-
teins which overload the folding capacity within the ER induces the ER
stress sensors, i.e., protein kinase RNA-like endoplasmic reticulum ki-
nase (PERK), activating transcription factor 6 (ATF6), and inositol-
requiring enzyme 1 (IRE1) which further activate the unfolded protein
response (UPR) signaling. Unfolded/misfolded proteins are retained and
directed to degradation by endoplasmic reticulum-associated degradation
(ERAD) system, apoptosis, or autophagy (reciprocal regulation, yellow
arrows). Under the quality control mechanisms, the ER stress aims to
restore the homeostasis within ER through regulation of protein entry into
the ER, folding, and degradation. Black arrows show the alternative path-
ways of the ER-Golgi-lysosomes/extracellular space axis depending on
the proper folding, unfolding, or misfolding of protein. Red, intermittent
arrows depict homeostatic control pathways (plus sign stimulatory,minus
sign inhibitory)
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2010). In certain circumstances when excessive ER stress fails
to induce apoptosis, autophagy might also serve as an alterna-
tive route leading to cell death and necrosis (Szegezdi et al.
2006; Suh et al. 2012; Ullman et al. 2008) (Fig. 2).
Endoplasmic reticulum stress and the diseases
Many inherited disorders of connective tissue are caused by
mutations in genes encoding structural components of the ex-
tracellular matrix (ECM) or enzymes that participate in their
posttranslational modifications and assembly. Often the muta-
tions interfere with ECM protein folding and inhibit their se-
cretion from the cell resulting in disruption of their function in
connective tissue. Therefore, although the prevailing para-
digm for inherited diseases of the ECM has involved predom-
inantly extracellular molecular pathology, more recently, an
increasing number of reports have shown that intracellular
processes may affect the pathology of these conditions as well
(Bateman et al. 2009).
Up to now, the role of ER stress and the activation of
pathways leading to UPR have been intensively investigated
in a number of neurodegenerative disorders, e.g., Alzheimer’s
and Parkinson’s diseases (Perri et al. 2016; Uehara et al. 2006;
Hoozemans et al. 2007; Ron et al. 2010), cancer (Chhabra
et al. 2015; Suh et al. 2012; Ha et al. 2015), and chronic
metabolic diseases such as obesity, insulin resistance, and type
2 diabetes (Hotamisligil 2010); in a number of lysosomal stor-
age disorders, e.g., Fabry’s and Gaucher’s diseases (Yam et al.
2006; Maor et al. 2013; Ron et al. 2010); and in the pathology
of diseases involving professional secretory tissues such as
cystic fibrosis and α1-antitrypsin deficiency (Bartoszewski
et al. 2011; Alam et al. 2014). Recent reports investigating
effects of mutations on assembly and secretion of several
ECM components suggest that multiple outcomes such as
misfolding and intracellular accumulation of mutant ECM
proteins may result from induction of ER stress (Chung
et al. 2009; Liang et al. 2014; Rajpar et al. 2009; Pieri et al.
2014; Firtina et al. 2009; Gould et al. 2007; Nugent et al.
2009; Bateman et al. 2009; Boot-Handford and Briggs 2010;
Yang et al. 2005).
Mutations leading to cartilage pathology
Cartilage is a connective tissue that serves multiple functions
during embryonic development and in postnatal life. It is com-
posed of collagenous proteins, mainly type II in hyaline carti-
lage, collagen type X, glycoproteins, proteoglycans, and gly-
cosaminoglycans (Sophia Fox et al. 2009; Yang et al. 2005).
The chondrocyte, the only resident cell found in cartilage,
proliferates and secretes ECM forming the cartilage template
of the skeleton during development. In adults, chondrocytic
cells produce and maintain ECM that participates in growth,
mechanical support, and function of diarthrodial joints be-
tween bones (Sophia Fox et al. 2009; Mackie et al. 2011).
Longitudinal bone growth is dependent on the strict temporal
regulation and control of chondrocyte proliferation, differen-
tiation, hypertrophy, apoptosis, and vascular invasion within
the growth plate by a complex network of regulatory mole-
cules and interactions of cells and ECM (Mackie et al. 2011;
Karsenty 2008; Karsenty et al. 2009). Until now, over 400
skeletal disorders have been described, and several are caused
by mutations in cartilage ECM genes that are critical to endo-
chondral ossification (Warman et al. 2011). Although individ-
ually rare, they cause a significant impact on the quality of life
for patients suffering from skeletal abnormalities. Genes
encoding cartilage ECM proteins affected by mutations which
disrupt growth plate differentiation comprise collagen types II,
IX, X, and XI; aggrecan; cartilage oligomeric matrix protein
(COMP); and matrilin 3 (Hintze et al. 2008; Chung et al.
2009; Liang et al. 2014; Ho et al. 2007; Mäkitie et al. 2010;
Kuivaniemi et al. 1997; Warman et al. 2011; Bateman et al.
2009; Boot-Handford and Briggs 2010; Yang et al. 2005;
Briggs et al. 2015). The list of collagenopathies associated
with mutations in collagen types II and X is presented in
Table 1.
Mutations in collagen type II
Collagen II, a main structural protein of cartilaginous tissues,
is first synthesized as procollagen, characterized by the pres-
ence of an extended triple-helical domain flanked by the glob-
ular N-terminal and C-terminal propeptides (Arnold and
Fertala 2013). Biosynthesis of procollagen molecules is a
complex process that involves posttranslational modifications
of the nascent pro-α chains. These modifications include hy-
droxylation of proline residues and lysine residues by prolyl-4
hydroxylase (P4H) and lysyl hydroxylase (LH), respectively.
In turn, the posttranslational modifications and formation of
the triple-helical structure are controlled by molecular chaper-
ones that belong to the group of proteins residing in the ER,
which includes heat shock protein 47 (HSP47), Grp78, and
protein disulfide isomerase (PDI), amongst which the latter
enzyme also acts as the β subunit of the αα/ββ tetramer that
constitutes functional P4H (Chung et al. 2009; Ono et al.
2012; Patterson and Dealy 2014). In addition, by binding to
the individual pro-α1(II) chains and preventing their prema-
ture association, P4H may also act as a chaperone during
biosynthesis of procollagen molecules. Procollagenmolecules
are released from the ER and directed toward secretory path-
ways following biosynthesis of individual pro-α1(II) chains,
their posttranslational modifications, and folding into triple-
helical structure (Chung et al. 2009; Ono et al. 2012).
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Table 1 Skeletal diseases associated with mutations in collagen types II and X




12q13.11 COL2A1 AD Type II
collagen
200610 Severe micromelic dwarfism,
incomplete ossification of the
vertebral bodies, disorganization of
the costochondral junction, small
chest, prominent abdomen
Nishimura et al. 2005;





12q13.11 COL2A1 AD Type II
collagen
183900 Disproportionate short stature (short
trunk), abnormal epiphyses,
flattened vertebral bodies, myopia,
and/or retinal degeneration with ret-
inal detachment and cleft palate




Kniest dysplasia 12q13.11 COL2A1 AD Type II
collagen
156550 Short stature, disproportionate (short
trunk), platyspondyly, lumbar
kyphoscoliosis, coronal vertebral
clefts, hypoplastic pelvic bones, hip
dislocation, delayed epiphyseal
ossification (early), megaepiphyses
(late), narrowing of joint spaces,




Stickler syndrome type 1
(arthro-ophthalmopathy)
12q13.11 COL2A1 AD Type II
collagen
108300 Clinically and genetically
heterogeneous disorder,
characterized by ocular, auditory,
skeletal, and orofacial abnormalities.
Most forms are characterized by the




midline clefting (cleft palate or bifid
uvula), Pierre Robin sequence, flat
midface, sensorineural or
conductive hearing loss, mild
spondyloepiphyseal dysplasia, and
early-onset OA
Nishimura et al. 2005;







12q13.11 COL2A1 AD Type II
collagen
151210 Decreased ossification of the skull
base, disc-like platyspondyly, short
thin ribs, hypoplastic pelvis with
wide sacrosciatic notches and flat
acetabular roof, short tubular long
bones with metaphyseal cupping
Nishimura et al. 2004;




12q13.11 COL2A1 AD Type II
collagen
184250 Severe dwarfism, superficially
resembling the Morquio syndrome,
pectus carinatum, and scoliosis
which are usually marked. Cleft
palate and retinal detachment
frequently associated, as in SEDc
(183900). A distinctive radiographic
feature is irregular sclerotic changes,
described as Bdappled^ in the
metaphyses of the long bones
Sulko et al. 2005;
Shapiro et al. 2006;
Czarny-Ratajczak
et al. 2009
Spondyloperipheral dysplasia 12q13.11 COL2A1 AD Type II
collagen
271700 Short stature, platyspondyly, mild
biconcave disc (fish-mouth
vertebrae), kyphosis, short ilia,
horizontal acetabulae, flattened
capital femoral epiphyses,
acetabular spurs (infancy), very
short distal phalanges (2nd, 3rd, 4th,
5th), short metacarpals (2nd, 3rd,
4th, 5th), cone-shaped epiphyses,
brachydactyly BE-like^ changes,
short feet, short phalanges, short
metatarsals (4th)
Zankl et al. 2004;
Bedeschi et al. 2011
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To date, about 330 records of mutations in collagen type II
α1 (COL2A1) that cause chondrodysplasias have been pub-
lished (Stenson et al. 2009). These mutations alter the gene
encoding the α1 chain of procollagen type II causing various
types of the disease, which can be lethal, i.e., hypochondro
dysplasia or deforming, i.e., spondyloepiphyseal dysplasia
congenita (SEDc), Kniest dysplasias, and Stickler syndrome
or may appear as mild knee and hip joint diseases (Nishimura
et al. 2005; Su et al. 2008; Warman et al. 2011; Arnold and
Fertala 2013; Li et al. 2014). The most frequent amino acid
substitutions in collagen type II occur at the G position of the
G-X-Y triplets; for instance, a G853E (p.G1053E) substitution
was found in a patient with a lethal form of SED. Some reports
described substitutions in the Yposition; for example, cysteine
substitutions for arginine residues were found in the Y posi-
tions 75 (p.R275C), 519 (p.R719C), and 789 (p.R989C) in
Table 1 (continued)




12q13.11 COL2A1 AD Type II
collagen
609162 Normal stature, mild platyspondyly,
irregular vertebral endplates, narrow
intervertebral disc spaces, irregular
sclerotic acetabulae, flattened capital
femoral epiphyses, narrow iliac
wings, narrow short femoral neck,
arthralgia, flexion contractures
(knee), osteochondromatosis (knee),
short metacarpals (4th–5th), onset of
joint pain in childhood, waddling
gait, hip replacement in early
adulthood, hearing loss
Hoornaert et al. 2007;
Tzschach et al.
2008; Matsui et al.
2009
Avascular necrosis of the femoral
head (ANFH)
12q13.11 COL2A1 AD Type II
collagen
608805 Patients present with groin pain, onset
of symptoms in 2nd to 5th decades
of life, degeneration of hip joint,
narrowing of joint space, avascular
necrosis/cystic changes/sclerosis of
femoral head, generalized osteopo-
rosis (in some patients), mild scoli-
osis (in some patients)
Liu et al. 2005;
Nishimura et al.
2005; Su et al.
2008; Kannu et al.
2011; Li et al. 2014
Legg-Calvé-Perthes disease
(LCPD)
12q13.11 COL2A1 AD Type II
collagen
150600 Disease onset between 6 and 9 years,
short stature, necrosis of capital
femoral epiphysis, more severe in
females, more frequent in males
Nishimura et al. 2005;
Miyamoto et al.
2007; Su et al.






12q13.11 COL2A1 AR Type II
collagen
215150 Short stature, sensorineural hearing
loss, epiphyseal dysplasia,
premature OA , midface hypoplasia,
increased lumbar lordosis, vertebral
coronal clefts (newborn), enlarged
odontoid (childhood),
platyspondyly (childhood), joint
contractures and pains, enlarged
joints, short hands/ fingers/
metacarpals, prominent
interphalangeal joints
Miyamoto et al. 2005
Metaphyseal (chondro) dysplasia,
Schmid type (MCDS, MCS)
6q21–
22.3
COL10A1 AD Type X
collagen
156500 Short stature (mild to moderate), adult
height 130–160 cm, mild
platyspondyly, coxa vara, femoral
and tibial bowing, metaphyseal
abnormalities of distal and proximal
femurs/proximal tibiae and fibulae/
distal radius and ulna, metaphyseal
cupping of proximal phalanges and
metacarpals, waddling gait, leg pain
during childhood
Mäkitie et al. 2005;
Ho et al. 2007;
Mäkitie et al. 2010
AD autosomal dominant; AR, autosomal recessive; COL2A1, collagen type II alpha 1; COL10A1, collagen type X alpha 1; OA, osteoarthritis
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patients with a mild form of SED, a mild form of OA, and a
severe form of SEDc (Hoornaert et al. 2006; Hintze et al.
2008). Relatively rare mutations comprise substitutions in
the X position of the G-X-Y triplets that were found in patients
with Stickler syndrome (Table 1) (Richards et al. 2000). For
example, Chung et al. (2009) investigated the R992C
(p.R1192C) substitution in the X position of a G-X-Y triplet
of collagen type II. Corresponding substitution (p.R1147C)
originally described in mice represents skeletal abnormalities
similar to those seen in patients with SEDc (Donahue et al.
2003). Using a system expressing recombinant collagen type
II, Chung et al. (2009) demonstrated that R992C mutant
caused aberrant electrophoretic mobility and was
characterized by relatively low thermostability and the
presence of intramolecular disulfide bonds. Additionally, the
expression of aberrant collagen type II was associatedwith ER
stress and increased apoptosis of cells producing the mutant.
Furthermore, Jensen et al. (2011) demonstrated the association
between excessive intracellular accumulation of the R992C
mutant molecules and ER stress using organotypic cartilage-
like constructs. Other substitution in collagen type II (R789C,
p.R989C) also caused misfolding of mutant molecules, de-
creased their thermostabilities, promoted excessive intracellu-
lar accumulation, and increased apoptosis (Hintze et al. 2008).
These results genuinely have shown that beyond the loss of
function effect, certain mutations in collagen type II may also
cause a gain-of-function, i.e., cytotoxic effect. Moreover,
these data contribute to the understanding of the molecular
basis of mutations that trigger pathological changes seen at
the level of skeletal tissues and suggest that mutations in
collagen type II associated with variations of thermostability
and disturbance of correct folding of the collagen triple helix
apart from the pathological impact on extracellular
collagenous framework also alter intracellular processes.
More recently, Arita et al. (2015) employed a SED mouse
model to analyze the morphology of the growth plate. This
model consists of conditional expression of the R992Cmutant
or the wild type (WT) transgene by using a tetracycline (Tet)-
modulated promoter, leading to the transgene being switched
off in the presence of doxycycline (Dox). Morphological anal-
yses of growth plates from newborn, 2-week-old, 6-week-old,
and 10-week-old mice suggest excessive accumulation of col-
lagen type II chains within dilated chondrocytes present in
growth plates of mice harboring R992C mutants. The pres-
ence of similarly dilated cells was neither observed in WT
mice nor mice maintained in Tet-off conditions. A histological
study of the tibial growth plates showed aberrations in growth
plate organization. In contrast to chondrocytes found in
growth plates of WT mice, the columnar organization of
chondrocytes in mice harboring R992Cmutant was disturbed,
alterations being indicated by the presence of disorganized
columns. Switching off the expression of the R992C mutant
in mice with Dox-regulated promoter maintained in Tet-off
conditions resulted in developing growth plates with correctly
organized chondrocytes (Fig. 3). Abundant collagen type II
deposits were noted in the extracellular spaces of growth
plates of WT mice, while in contrast, in mice with the muta-
tion, the extracellular content of collagen type II was signifi-
cantly reduced and its increased intracellular accumulation
was clearly visible. Analysis of Sirius red-stained deposits of
collagen fibrils present in the growth plates of WT mice indi-
cated their organized pattern of distribution in the longitudinal
septa present between adjacent columns of chondrocytes. By
contrast, the collagenousmatrix present in the growth plates of
the mice harboring collagen type II mutant lacked clear struc-
tural continuity, and the longitudinal septa were irregularly
thickened. In summary, the studies with transgenic mice
have shown that the presence of R992C collagen type II
results in skeletal aberrations that include alterations of the
linear growth. Aberrant columnar organization of
chondrocytes was associated with ER stress, abnormal
architecture of collagenous matrix, unusual organization of
primary cilia, atypical cell polarization, and reduced
proliferation of chondrocytes harboring the mutation. In
turn, Liang et al. (2014) constructed a mouse model harboring
the p.G1170S mutation in collagen type II. Severe defects in
skeletal development (chondrodysplasia phenotype) were ob-
served in homozygotes, but not in heterozygotes.
Homozygous fetuses were smaller, with shortened and wid-
ened long bones, abnormal scapulae, shapeless pelvises, non-
ossified middle phalanges, malformed ribcages, and less-
mineralized vertebrae. These defects indicate that cartilage
shaping was disturbed in mice lacking normal collagen type
II and endochondral ossificationwas slowed. In contrary, skel-
etons from heterozygotes resembled wild types by appear-
ance. Abnormal features of the skeleton were confirmed at
the molecular level as well. Chondrocytes in the resting zones
of homozygotes were normally distributed; however, the pro-
liferating zones consisted of fusiform cells decreased in num-
ber, aligned transversely and chaotically, while the hypertro-
phic zone was lost. Proteoglycans, collagen type II, and ex-
pression of SOX9 (which regulates the expression of collagen
type II) in the growth plate were significantly decreased in
homozygotes. The analysis of cultured chondrocytes collected
from embryonic cartilage by a confocal microscope showed
that mutated type II procollagen in homozygotes assembled
into bundles, co-localized with the ER, and was retained in-
tracellularly. Intracellular accumulation resulted in ER disten-
tion and ER stress-UPR-apoptosis cascade activation.
Additionally, expression of several ER stress-related genes,
corresponding to CHOP, total XBP1 (tXBP1), spliced XBP1
(sXBP1), Grp78, ATF4, and ATF6, was upregulated in homo-
zygotes and partly increased in heterozygotes. Cell apoptosis
prevented the formation of a hypertrophic zone and disrupted
normal chondrogenic signaling pathways. In consequence, in
homozygotic mice harboring the p.G1170S mutation,
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abnormally developed growth plate was found. In contrast,
heterozygotes had normal phenotypes with limited ER stress.
These results suggest that chondrocytes’ death related to ER
stress-UPR-apoptosis cascade was a crucial cause of
chondrodysplasia.
A novel COL2A1 missense mutation (p.D1469A) in mice
was identified, which was situated in the C-propeptide region
of α1 chain (Furuichi et al. 2011). Mutation in this position
corresponds to human COL2A1 mutation responsible for
platyspondylic lethal skeletal dysplasia, Torrance type
(PLSD-T). Skeletal defects found in the homozygotes were
similar to those in PLSD-T patients. Accumulation of mutant
proteins in abnormally expanded rough ER was accompanied
by disrupted secretion of this mutant protein into extracellular
space and upregulation of ER stress-related genes, corre-
sponding to Grp78 and CHOP in chondrocytes (Table 2).
Mutations in collagen type X
Collagen type X belongs to non-fibrillar collagens produced
by chondrocytes residing within the hypertrophic zone of
mammalian growth plates. Each protein chain consists of a
carboxyl-terminal non-collagenous domain (NC1), the main
triple-helical domain, an amino-terminal non-collagenous do-
main (NC2), and a signal peptide. Collagen trimers are stabi-
lized and propagate correctly from the C- to the N-terminal
end of the molecule as a result of potent hydrophobic interac-
tions between the NC1 domains. Missense, nonsense, and
frameshift mutations in collagen type X alpha1 (COL10A1)
cause MCDS. Forty of the 42 reported mutations alter the
NC1 domain, whereas two alter the signal peptide cleavage
site of the collagen type X protein chain. Both,
haploinsufficiency and dominant-negative mechanisms have
been reported. Affected individuals are clinically normal at
birth, but after they start walking, they develop a dispropor-
tionate short stature. The shortening and deformities of the
long bones are due to impaired function of the thickened and
irregular growth plates (Table 1) (Warman et al. 2011; Mäkitie
et al. 2005; Bateman et al. 2003, 2005; Chan et al. 1998).
Several reports of in vitro protein assembly assays, analy-
ses of human MCDS cartilage, as well as transgenic mouse
models of MCDS provided evidence that COL10A1 muta-
tions inducing MCDS result in some mRNA degradation,
but also determine a gain-of-function effect on the growth
plate. For instance, MCDS probant heterozygous for a
p.Y663X nonsense mutation produced a truncated α1(X)
chain lacking the last 18 amino acids of the NC1 domain that
Fig. 3 Histology of the tibial growth plates of the 10-week-old
WTProGFP(−) (a, e), WTProGFP(+) (b, f), R992CProGFP(−) (c, g), and
R992CProGFP(+) (D,H) mice maintained in the absence (A–D) or presence
(E–H) of Dox. In contrast to chondrocytes seen in the growth plates of the
10-week-old WTProGFP(−) (a), WTProGFP(+) (b), and R992CProGFP(−) (c)
mice, the columnar organization of chondrocytes in the R992CProGFP(+)
littermates was altered (d). For instance, in the R992CProGFP(+) mice, such
alterations were indicated by the presence of disorganized columnswhose
continuity of the typical palisade-like arrangement was often interrupted
by extended areas in which the chondrocytes were absent (d). Switching
off the expression of the R992C ProGFP in the DoxR992CProGFP(+) mice
maintained in Tet-off conditions resulted in developing growth plates in
which chondrocytes were organized correctly (h). Growth plates from
these mice had a normal morphology comparable to that seen in the
DoxR992CProGFP(−) littermates (g) as well as their DoxWTProGFP(−) and
DoxWTProGFP(+) counterparts maintained in Tet-off conditions (e, f)
(reprinted from the American Journal of Pathology (Arita et al. 2015)
with permission from Elsevier)

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































did not form stable homotrimers and were unable to form
stable heterotrimers with WT α1(X) chains. Iliac crest growth
plate cartilage from the probant contained 64 % of WT and
36 % of mutant mRNA, and the hypertrophic zone was disor-
ganized and expanded (Ho et al. 2007). In turn, in transgenic
FCdel mice corresponding to a human MCDS, p.P620fsX621
mutation showed an early-onset MCDS phenotype with dis-
proportionate shortening of the limbs and coxa vara deformi-
ties of the femoral necks. The severity of changes correlated
with higher copy numbers/expression of the transgene and
increased levels of sXBP1. The FCdel α1(X) chains that
lacked the C-terminal 60 amino acids of the NC1 domain were
synthesized by the HC, but the protein accumulated within the
ER. Retention of the FCdel α1(X) chains was associated, in a
concentration-dependent manner, with increased thickness
and abnormal maturation of the hypertrophic zone.
Thickening of the hypertrophic zones of the FCdel+/− and
FCdel+/+ mice, in the absence of endogenous collagen type
X, indicated that the retained protein was accompanied by a
gain-of-function effect, activating ER stress signaling and af-
fecting growth plate maturation (Ho et al. 2007). Another
group constructed mutants predicted either to prohibit subunit
folding and assembly (NC1del10 and p.Y598D, respectively)
or to allow trimerization and secretion of mutated α1(X)
chains (p.N617K and p.G618V). All four mutations resulted
in the formation of aberrant disulfide bonds and significantly
increased amounts of BiP, and the sXBP1 mRNA, two key
markers of the UPR (Wilson et al. 2002, 2005). In the study of
Rajpar et al. (2009), a knock-in mouse model of the
COL10A1 (p.N617K) mutation inducing MCDS was gener-
ated. It has been demonstrated that the MCDS-associated ex-
panded hypertrophic zone occurred because of disrupted vas-
cular endothelial growth factor (VEGF)- mediated osteoclast
erosion of the mineralized cartilage at the vascular invasion
front. ER stress and a strong UPR caused by misfolding mu-
tant collagen type X were key features of the hypertrophic
chondrocytes in the MCDS mouse. Furthermore, the targeted
stimulation of ER stress in hypertrophic chondrocytes in vivo
was sufficient to replicate the MCDS growth plate phenotype
functionally, demonstrating the central role played by ER
stress in the disease mechanism. Similar results were reported
in a MCDS-expressing transgenic mouse line harboring a 13-
bp deletion in COL10A1 (13del). Mutant collagen type X
molecules were accumulated within hypertrophic
chondrocytes that underwent ER stress which lead to altered
chondrocyte differentiation (Table 2) (Tsang et al. 2007). It is
therefore possible, that in vivo interference with the assembly
of collagen type X acts dominantly negative, resulting in poor
or no secretion of mutant homotrimers and heterotrimers and
reduced amounts of normal collagen type X in the ECM. In
the absence of mutant collagen type X in the ECM, the phe-
notype could be attributed to haploinsufficiency for collagen
type X (Chan et al. 1998; Bateman et al. 2003). However, if
mutant collagen type X is secreted to the ECM, there could be
a dominant-negative effect on structural properties of ECM.
Conclusions and perspectives
The endoplasmic reticulum is one of the major cellular sites
for the synthesis, maturation, and folding of secreted, mem-
brane-bound, and organelle-targeted proteins. Perturbations of
ER homeostasis via acceleration of unfolded or misfolded
proteins cause a stress condition for this organelle. To deal
with it and restore a more favorable folding environment,
the ER triggers an evolutionarily conserved signaling cascade,
named UPR. In addition to physiological processes, increas-
ing evidence suggests that ER stress is involved in certain
groups of diseases, for instance neurodegenerative and meta-
bolic diseases as well as in some malignancies, occurring as a
result of protein aggregation. Moreover, an increasing number
of reports cite ER stress as a novel mechanistic paradigm of
connective tissue diseases caused by mutations in several
types of collagens. This refers to mutations in collagen type
VI that induce mild to severe phenotype of myopathies and
mutations in collagen type IV that are responsible for devel-
oping of nephropathies, ocular dysgenesis, brain
malformations, or cerebral hemorrhages. More importantly, a
significant number of reports from in vitro studies and mice
models with skeletal abnormalities corresponding to
chondrodysplasias point to ER stress as amechanism involved
in the pathogenesis of these group of diseases.
Chondrodysplasias comprise a wide spectrum of pheno-
types predominantly affecting cartilage and bone, from the
severe disorders that are perinatally lethal to the milder con-
ditions that are recognized in the postnatal period and child-
hood. The milder chondrodysplasias are characterized by dis-
proportionate short stature, eye abnormalities, cleft palate, and
hearing loss. Treatment is difficult and limited, particularly
when the pathological process begins before birth and can
affect the entire skeletal system. Additionally, considering po-
tential pleiotropic effects of mutant genes, patients suffering
from chondrodysplasias may have complications with central
and peripheral nervous system, bonemarrow, immune system,
kidney, heart, etc.
This review focuses on basic mechanisms of ER stress and
its significance in certain variants of chondrodysplasia caused
by mutations in collagen types II and X. Regarding collagen
type II, the following are discussed: substitutions in the X po-
sition of a G-X-Y triplet that are present with skeletal abnor-
malities similar to those seen in patients with SEDc; substitu-
tions in the Y position that lead to abnormalities found in pa-
tients with amild form of SED, amild form of OA, and a severe
form of SED; as well as a missense mutation in the C-
propeptide region of α1 chain which is associated
with PLSD-T. Considering collagen type X, missense,
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nonsense, and frameshift mutations responsible forMCDShave
been described on the basis of reports from in vitro protein
assembly assays, analyses of human cartilage, as well as trans-
genic mice models. The retained collagen type II/X mutant
proteins caused a gain-of-function effect on the growth plate
activating ER stress signaling and affecting growth plate orga-
nization with decreased thermostability and excessive intracel-
lular accumulation of mutant molecules leading to apoptosis of
cells producing collagen mutants as a hallmark. Taking togeth-
er, efforts should be undertaken in the future investigations to
verify the observations from the studies discussed herein, which
showed a significant contribution of the ER stress and associat-
ed downstream signaling as a pathogenic mechanism of certain
variants of chondrodysplasia. A better understanding of this
association would be advantageous in designing preventive
strategies, early ameliorative management, and/or perhaps nov-
el therapies of the individuals being at risk of developing skel-
etal diseases. Such interventions potentially translate into a re-
duction in health costs associated with musculoskeletal disease.
ACG2, achondrogenesis type II; ATF4, activating tran-
scription factor 4; ATF6, activating transcription factor 6;
AS, Alport syndrome; AD, autosomal dominant; AR, autoso-
mal recessive; ANFH, avascular necrosis of the femoral head;
bZIP transcription factor, basic leucine zipper; BM, Bethlem
myopathy; CNX, calnexin; CRT, calreticulin; CREBH, cAMP
response element binding protein H; COMP, cartilage oligo-
meric matrix protein; C/EBP, CCAAT/enhancer binding pro-
tein; CHOP, CCAAT/enhancer binding protein homologous
protein; COL2A1, collagen type II α1; COL10A1, collagen
type X α1; DOX, doxycycline; ER, endoplasmic reticulum;
ERAD, endoplasmic reticulum-associated degradation sys-
tem; ERSE, ER stress response element; eIF2α, eukaryotic
translation initiation factor 2α; ECM, extracellular matrix;
Grp78, glucose-regulated protein 78 kDa; Grp94, glucose-
regulated protein 94 kDa; HSP47, heat shock protein 47;
IRE1, inositol-requiring enzyme 1; LCPD, Legg-Calvé-
Perthes disease; LH, lysyl hydroxylase; MCDS/MCS,
metaphyseal (chondro) dysplasia, Schmid type; OASIS, old
astrocyte specifically induced substance; OA, osteoarthritis;
OI, osteogenesis imperfecta; OSMED, otospondylome
gaepiphyseal dysplasia; PLSD-T, platyspondylic lethal skele-
tal dysplasia, Torrance type; P4H, prolyl-4 hydroxylase; PDI,
protein disulfide isomerase; PERK, protein kinase RNA-like
endoplasmic reticulum kinase; PQCS, protein quality control
system; RIP-regulated liver-specific transcription factor, reg-
ulated intramembrane proteolysis; sXBP1, spliced variant of
X-box binding protein 1; SEMD, spondyloepimetaphyseal
dysplasia, Strudwick type; SED, spondyloepiphyseal dyspla-
sia; SEDc / SDC, spondyloepiphyseal dysplasia congenita;
TBMN, thin-basement-membrane nephropathy; tXBP1, total
X-box binding protein 1; UPP, ubiquitin proteasome pathway;
UCMD, Ullrich congenital muscular dystrophy; UPR, unfold-
ed protein response; UPRE, UPR element; VEGF, vascular
endothelial growth factor; WT, wild type; XBP1, X-box bind-
ing protein 1.
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